Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     

  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     

  • Bitcoin GBP

    50,499.96
    -1,017.73 (-1.98%)
     

  • CMC Crypto 200

    1,304.48
    -92.06 (-6.59%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • DOW

    38,239.66
    +153.86 (+0.40%)
     

  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     

  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Global Typhoid Fever Vaccines Markets to 2027: Development of Innovative and Potent Vaccine Candidates Gaining Momentum

Research and Markets
·4-min read

Dublin, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The "Typhoid Fever Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Vaccine Type; Route of administration, and Geography." report has been added to ResearchAndMarkets.com's offering.

The market is expected to reach US$ 525.32 million by 2027 from US$ 262.81 million in 2019 and is estimated to grow with a CAGR of 9.3% from 2020 to 2027.

Based on vaccine type, the market is segmented in to live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. In 2019, the capsular polysaccharide vaccines segment accounted for the highest share of the market. Growth of this segment is attributed to the effectiveness associated with in preventing infections and increasing patient pool across the globe. The Live Attenuated Vaccine segment is likely to register highest CAGR in the global Typhoid fever vaccines market during the forecast period.

Global Typhoid fever vaccines Market, based on route of administration, the Typhoid fever vaccines market is segmented into oral and injections. The injectable segment held the largest share of the market in 2019, whereas the oral segment is anticipated to register the highest CAGR of 10.1% in the market during the forecast period.

COVID-19 pandemic has become the most significant challenge across the world. This challenge will be frightening especially in developing countries across the globe as it will lead to reducing imports due to disruptions in global trade, which further increases the shortages of medical supplies and other goods, resulting in a considerable price increase.

The World Health Organization and UNICEF warned an alarming decline in the number of children receiving life-saving vaccines around the world. This is due to disruptions in the delivery and uptake of immunization services caused by the COVID-19 pandemic. In 2019, UNICEF procured an estimated 2.43 billion doses of vaccines to around 100 countries to reach around 45% of the world's children below the 5-year-old age group.

Shanghai Institute of Biological Products Co. Ltd., Bharat Biotech, Sanofi, GlaxoSmithKline, Paxvax Inc. PT Bio Farma, BIO-MED, Prokarium Ltd & Scandinavian Biopharma are among the leading companies operating in the Typhoid fever vaccines market.

Key Topics Covered:

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation

2. Typhoid Fever Vaccines Market - Key Takeaways

3. Research Methodology

4. Global Typhoid Fever Vaccines - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinions

5. Typhoid Fever Vaccines Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Number of Patients Suffering with Typhoid
5.1.2 Organizations Supporting Typhoid Immunizations
5.2 Market Restraint
5.2.1 Risk of Side-Effects Associated with Typhoid Fever Vaccines
5.3 Market Opportunity
5.3.1 Outsourcing Pharmaceutical Research
5.4 Future Trend
5.4.1 Development of Innovative and Potent Vaccine Candidates
5.5 Impact Analysis

6. Typhoid Fever Vaccines Market - Global Analysis
6.1 Global Typhoid Fever Vaccines Marker Revenue Forecast And Analysis
6.2 Global Typhoid Fever Vaccines Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players

7. Typhoid Fever Vaccines Market - By Vaccine Type
7.1 Overview
7.2 Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)
7.3 Live Attenuated Vaccine
7.4 Capsular Polysaccharide Vaccines
7.5 Conjugate Vaccine

8. Typhoid Fever Vaccines Market Analysis - By Route of Administration
8.1 Overview
8.2 Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)
8.2.1 Oral
8.3 Injectable

9. Typhoid Fever Vaccines Market Analysis And Forecast To 2027 - Geographical Analysis

10. Impact of COVID-19 Pandemic on Global Typhoid Fever Vaccines Market

11. Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.4 Inorganic Developments

12. Company Profiles
12.1 Key Facts
12.2 Business Description
12.3 Products and Services
12.4 Financial Overview
12.5 SWOT Analysis
12.6 Key Developments

  • Shanghai institute of biological products co., ltd.

  • BHARAT BIOTECH

  • Sanofi

  • GlaxoSmithKline plc.

  • Paxvax Inc.

  • PT Bio Farma

  • BIO-MED

  • Prokarium Ltd.

  • Scandinavian Biopharma

For more information about this report visit https://www.researchandmarkets.com/r/y7mihe

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

ADVERTISEMENT
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900